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Deformed wing virus (DWV) is the most important globally distributed pathogen of honey bees and, when vectored by the
ectoparasite Varroa destructor, is associated with high levels of colony losses. Divergent DWV types may differ in their pathogenicity
and are reported to exhibit superinfection exclusion upon sequential infections, an inevitability in a Varroa-infested colony. We
used a reverse genetic approach to investigate competition and interactions between genetically distinct or related virus strains,
analysing viral load over time, tissue distribution with reporter gene-expressing viruses and recombination between virus variants.
Transient competition occurred irrespective of the order of virus acquisition, indicating no directionality or dominance. Over longer
periods, the ability to compete with a pre-existing infection correlated with the genetic divergence of the inoculae. Genetic
recombination was observed throughout the DWV genome with recombinants accounting for ~2% of the population as
determined by deep sequencing. We propose that superinfection exclusion, if it occurs at all, is a consequence of a cross-reactive
RNAi response to the viruses involved, explaining the lack of dominance of one virus type over another. A better understanding of
the consequences of dual- and superinfection will inform development of cross-protective honey bee vaccines and landscape-scale
DWV transmission and evolution.
The ISME Journal; https://doi.org/10.1038/s41396-021-01043-4
INTRODUCTION
Honey bees (Apis mellifera) are globally important pollinators of
wild flowers and agricultural crops, and the source of honey, with
annual global production worth in excess of $7bn [1]. Both honey
production and pollination services require strong, healthy
colonies, which are threatened by a range of factors, but most
significantly by disease. One of the major viral pathogens of honey
bees is Deformed wing virus (DWV). When transmitted by the
parasitic mite Varroa destructor, DWV is responsible for high
overwinter colony losses, which can exceed 37% annually [2].
Improvements to honey bee health, through direct control of virus
transmission or replication, require a better understanding of how
the virus propagates within and between bees.
The historical identification and naming of DWV-like viruses
imply a greater genetic divergence than subsequent molecular
analysis has demonstrated. In 2004–2006 several picorna-like
viruses with high levels of sequence identity were reported [3–5].
These viruses were initially named according to their origins; the
virus from honey bees with characteristic wing deformities was
termed DWV [4], a similar virus found in aggressive workers in
Japan was designated Kakugo virus [3, 5] and analysis of Varroa
mites yielded Varroa destructor virus type 1 (VDV-1) [3]. Limited
genetic divergence (~84–97% genomic RNA identity), similar
infectivity in honey bees, and demonstrated ability to freely
recombine during coinfections [6–9] resulted in them now being
considered as different variants of DWV [6, 7, 10], albeit occupying
two genetic branches (VDV-1-like and DWV-like) of the same
phylogenetic tree [11]. To distinguish between these branches the
terminology ‘type A’ and ‘type B’ has been adopted for DWV-like
and VDV-1-like variants respectively. Evidence for the existence of
a third type named DWV type C has also been reported [12].
DWV is ubiquitous in honey bees [13–15], with the possible
exception of Australian colonies [16]. In the absence of Varroa
the virus is transmitted horizontally, per os, and vertically from the
infected queen and the drones [17]. With subsequent Varroa mite
transmission it is therefore inevitable that the virus enters a host
already harbouring one or multiple DWV variants. Current studies
suggest that DWV infection can occur with several variants
cocirculating in the same apiary, colony, or individual honey bee
host [18–21]. Although the type A and B variants appear to be
differentially distributed, with type A frequently reported in the US
and type B being commonly detected in European colonies
[8, 13, 22], direct competition may occur where they cocirculate. If
this competition has a directionality, it will influence the
distribution and future spread of DWV at the landscape scale.
While some studies of mixed DWV infections demonstrate no
predominance of one variant over another [18, 23], others show
possible competition between the variants and higher accumula-
tion of DWV B in infected bees [24]. In addition, superinfection
exclusion (SIE) has been proposed, in which a pre-existing type B
virus prevents the establishment of a type A infection at the
colony level [10].
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A recently developed reverse genetics (RG) system comprising a
set of genetically tagged DWV variants and reporter gene-
expressing viruses provides an opportunity to investigate coinfec-
tion kinetics and competition between DWV types [25]. Since SIE is
a widely observed virological phenomenon [26–35], we extended
these studies to assay dominance of one variant over another
during sequential infection. Using reporter gene-expressing DWV
we additionally investigated the influence of competition on tissue
distribution of infection. We show that where competition is
observed, manifested as reduced virus levels, it is reflected in
reduced reporter gene expression at the cellular level. Notably we
show that DWV accumulation during superinfection is influenced
by the genetic identity between the viruses, rather than by a
directionality of competition. Genetically divergent DWV variants
(such as those representing type A and type B) exhibit transient
competition, whilst viruses with greater identity (e.g. type A/B
recombinants with either type A or type B) demonstrate a distinctly
more pronounced effect. We also analysed the occurrence and
identity of recombinants during mixed infections and confirmed
that these are present with junctions widely distributed through-
out the genome. These studies provide further insights into the
biology of DWV. In particular they address the consequences of co-
and superinfection, an important consideration when transmitted
by the ectoparasite Varroa. Our results indicate that genome
identity is the determinant that defines the outcome of dual
infections; this will inform studies of population transmission at the
landscape scale and possible future developments of ‘vaccines’ to
protect honey bees from viral disease [36].
MATERIALS AND METHODS
RG DWV clones preparation
VDD, VVD and VVV RG constructs used in this study were described earlier
[25], DDD RG cDNA was prepared by modification of the VDD RG system
with a DWV type A parental sequence insert, which was based on
published data [37] and obtained by custom gene synthesis (IDT, Leuven,
Belgium). Enhanced green fluorescent protein (EGFP) and mCherry-
expressing chimeric DWV genomes were built via incorporation of the
reporter-encoding sequence into DWV cDNA as described previously [25].
All plasmid sequences were verified by Sanger sequencing. cDNA
sequences of DDD, VVVmC, and VVDs are shown in Text S1, other RG
cDNAs are available online (GenBank accession numbers: DWV-VDD -
MT415949, DWV-VVD (VVDH) - MT415950, DWV-VVV - MT415952, DWV-
VDD-eGFP - MT415948, DWV-VVD-eGFP - MT415953).
Viral RNA and siRNA synthesis
DWV RNA was synthesised from linearised plasmid templates with T7
RiboMAX Express Large Scale RNA Production System (Promega, South-
ampton, UK), and purified with the GeneJet RNA Purification Kit (Thermo
Fisher Scientific) as described in [25].
siRNA strands were prepared using Express Large Scale RNA Production
System (Promega) according to the manufacturer’s protocol with double
stranded DNA templates annealed from synthetic oligonucleotide pairs
containing T7 RNA polymerase promoter sequence (Table S1).
Viruses
Infectious DWV was prepared from honey bee pupae injected with in vitro
generated RNA as previously described [25, 38]. For quantification RNA was
extracted from 100 μl of virus preparation using the RNeasy kit (Qiagen,
Manchester, UK) and analysed by reverse transcription and quantitative
PCR (qPCR).
Honey bees and bumble bees
All honey bee (Apis mellifera) brood in this study was obtained from the
University of St Andrews research apiary. Colonies were managed to
reduce Varroa levels and endogenous DWV levels were regularly tested.
Honey bee larvae and both honey and bumble bee pupae (Bombus
terrestris audax, Biobest, Belgium) were maintained and fed as described
previously [25, 38].
Virus inoculations
Virus injections of pupae were performed with insulin syringes (BD Micro
Fine Plus, 1 ml, 30 G, Becton Dickinson, Oxford, UK) as described in [25, 38].
Oral larval infection was carried out by single DWV feeding according to
the previously described procedure [25].
RNA extraction, reverse transcription and PCR (RT-PCR)
RT-PCR and qPCR analysis of individual pupae samples was performed as
previously described [25]. Sequences of primers are shown in Table S1.
When required, PCR products were subjected to restriction digest prior to
loading on the 1% agarose gels stained with ethidium bromide. DWV titres
were calculated by relating the resulting Ct value to the standard curve
generated from a serial dilution of the cDNA obtained from the viral RNA
used for virus stock preparation.
Microscopy
Imaging was conducted using a Leica TCS SP8 confocal microscope with
10 × HC PL FLUOTAR objective. For dissected pupae analysis samples were
mounted in a drop of PBS under the microscope cover slides and observed
by microscopy within 1 h after the dissection.
Sample libraries for next generation sequencing
RNA was reverse transcribed using Superscript III polymerase (Invitrogen,
Thermo Fisher Scientific) with DWV FG RP1 primer (Table S1) using 1 µg of
total RNA in a 20 µl final reaction volume and following the manufac-
turer’s protocol. Reactions were incubated at 50 °C for 1 h, 75 °C for
15 min.
The transcribed cDNA was amplified using LongAmp Taq polymerase
(New England Biolabs) to produce a ~10 Kb PCR fragment. The reactions
were carried out according to the manufacturer’s protocol with the
following thermal profile: 30 s at 95 °C, 30 cycles of 95 °C for 15 s, 53 °C for
30 s, and 65 °C for 8 min, with a final extension at 65 °C for 10min.
Recombination analysis
Purified amplicons were sequenced using an HiSeq (Illumina, Cabmridge,
UK) at the University of St Andrews, producing 2 × 300 bp paired-end
reads. The sequences were converted to FASTA format, extracted and
trimmed using Geneious (v.2019.1.3). A reference genome file was made
using VVV and VDD cDNA sequences with a terminal pad of A-tails added
to maximise sensitivity [39]. The reference file was indexed using Bowtie
Build (Version 0.12.9) and the reads were mapped to the reference file
using the recombinant-mapping algorithm, ViReMa (Viral-Recombination
Mapper, Version 0.15). The recombinant sequences were compiled as a
text file and analysed using ggpubr (v2.3) in R Studio.
RESULTS
Modular RG system design for DWV
To compare the virulence and competitiveness of DWV types
and their recombinants a set of cDNA clones were prepared. By
exploiting the modular organisation of the DWV genome [9, 21]
we have previously constructed infectious cDNAs for several
distinct genetic variants of DWV [25]. For convenience these are
referred to as follows: VDD (DWV type A coding sequence,
GenBank MT415949), VVD (a type B/A recombinant, GenBank
MT415950), and VVV (DWV type B, GenBank MT415952). In
addition, we constructed a cDNA for a complete type A DWV,
designated DDD, using a similar gene synthesis and module
replacement strategy [25] to incorporate the DWV type A 5′-
untranslated region (5′-UTR; DWV-A 1414, GenBank KU847397
used as a reference—Fig. S1). VDD, VVV, and VVD DWV variants
were previously shown to be infectious and cause symptomatic
disease in honey bees [25]. Infectivity of the DDD virus was
verified by analysis of DWV accumulation in injected pupae and
was indistinguishable from the VDD virus (Fig. S2a). Derivatives
of VDD, VVD, and VVV, expressing EGFP or mCherry, were
generated as previously described [25] (Fig. S1) and their
replication verified following inoculation of pupae (for example,
Fig. S2b).















Superinfection and coinfection studies
Varroa delivers DWV to developing honey bee pupae by direct
injection when feeding. Pupae will already contain previously
acquired DWV and the mite may contain one or more DWV
variants. We investigated the consequences of coinfection and
superinfection on accumulation of distinct DWV variants in honey
bee pupae under laboratory conditions. Primary infection was
achieved by feeding first instar larvae (0–1 day old) with a diet
containing 107 genome equivalents (GE) of either VDD or VVV
DWV, followed by secondary inoculation by injection (103 GE) with
the reciprocal virus variant 10 days later at the white-eyed pupal
stage. The viral load in individual pupae was analysed by qPCR
24 h post-injection using DWV type-specific primers for the RNA-
dependent RNA polymerase (RdRp) coding region. In the absence
of superinfection, larvae fed either VDD or VVV showed
accumulation of the virus to levels of ~1010 GE/μg RNA by the
time of pupation (Fig. S2c). Pupae initially infected by larval
feeding and subsequently superinfected by injection showed a
markedly reduced accumulation of the injected DWV variant when
compared to the same virus in pupae which were not fed DWV as
larvae (Fig. 1a).
Reduced accumulation of a superinfecting virus was also
observed when white-eyed pupae were initially injected with
VDD or VVV 24 h prior to introduction of the reciprocal virus
variant (first injection—102 GE, superinfection—106 GE, Fig. 1b). In
contrast, simultaneous infection with two or three (VDD, VVV and
VVD) DWV variants (102 GE in total virus injected corresponding to
0.5 × 102 or 0.33 × 102 GE of each variant for two- and three-
component infections respectively) resulted in nearly equivalent
virus loads, although the VDD variant accumulated to slightly
lower (~0.5 log10) titres at 24 h post-injection.
Dynamics of DWV accumulation in superinfection conditions
We extended these studies to determine whether the apparent
competitive disadvantage for the second virus remained after an
extended incubation period. Pupal injections were repeated as
before and viral loads quantified 5 and 7 days after superinfection.
A recombinant type B/A variant (VVD) was additionally included
both as primary and superinfecting virus. In reciprocal infections
using VDD and VVV both the initial and the superinfecting virus
reached nearly equivalent levels within the incubation period
(Fig. 2). In contrast, in virus pairings with a greater sequence
identity between the genomes the superinfecting virus exhibited
a reduced accumulation even after prolonged incubation. In the
“VDD→ VVD”, “VVD→ VDD”, and “VVD→ VVV” groups the super-
infecting virus levels were ~2 log10 lower than the initial inoculum
at 5–7 days post-injection. For the “VVV→ VVD” pairing this was
more marked, with the superinfecting virus still ~4 log10 lower
after 7 days. In control pupae infected with VDD, VVD or VVV
individually all three viruses reached high titres 7 days post-
injection (Fig. 2 and Fig. S3). In addition, virus accumulation was
monitored after coinfection of equal amounts of each combina-
tion of VDD, VVD and VVV over time. In these studies, all
coinfecting variants achieved similar titres 5 days post-inoculation
(Fig. S3).
We recently demonstrated that bumble bees are susceptible to
DWV infection when directly injected at high doses [38]. We






































































































Fig. 1 Coinfection and superinfection of honey bee brood with DWV. a Superinfection of honey bee pupae preliminarily infected per os at
larval stage and then via injection at pupal stage. Quantified viral titres of VVV and VDD DWV in pupae 24 h post-injection of the
superinfecting virus are shown (second virus inoculated by injection after primary infection by feeding with the reciprocal DWV variant is
indicated by “→”, e.g. VVV (fed) → VDD (injected)). b DWV accumulation in honey bee pupae in coinfected (mixed virus population indicated
by “+”) or superinfected samples (second injection 24 h after primary infection by injection is indicated by “→”). Primer pairs for type A or type
B RdRp amplifying variant-specific fragments of virus polymerase encoding region were used to distinguish between the administered
variants. Data points represent DWV levels in individual pupae with two points of different colour corresponding to different virus variants
(red for type A RdRp and blue for type B RdRp respectively) in the same pupa (or in individual pupae for VVV or VDD only injected samples).
Error bars show mean ± SD for each virus variant in each injection group, GE—genome equivalents. ANOVA: p < 0.05 for type A accumulation
in “Mock→VDD” vs. “VVV→ VDD”, for type B in “Mock→VVV” vs. “VDD→ VVV” groups, for type A vs. type B in “VVV+ VDD” and “VVV+ VVD+
VDD” groups.
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the DWV superinfection by conducting similar experiments in
bumble bee pupae. At 48 h post superinfection the levels of the
second virus administered were lower than that of the primary
virus inoculated but—with the exception of the “VVD→ VVV”
combination—had achieved similar levels by 6 days post-injection
(Fig. S4).
These results suggest that a superinfecting virus experiences an
initial competitive disadvantage, but that this disadvantage is
overcome after 5–7 days unless the viruses exhibit more extensive
sequence identity. To investigate this further we studied super-
infection with essentially identical viruses, using two VVD variants
distinguishable solely by unique genetic tags—VVDS and VVDH,
tagged with a SalI or HpaI restriction site respectively (Fig. S1,
Text S1)—which differ by just four nucleotides. Honey bee pupae
injected with VVDH were challenged 24 h later with VVDS and
analysed by end point PCR and restriction assay 1, 3 and 6 days
after superinfection. No VVDS was detectable in superinfected
pupae at any time point analysed (Fig. S5) suggesting a complete
or near-complete block of the superinfecting genome amplifica-
tion. Control injections of VVDS into pupae, which did not receive
VVDH virus, allowed detection of SalI-tagged cDNA 24 h post-
inoculation.
Tissue localisation studies using reporter-encoding DWV
Total RNA levels analysis allows the quantification of DWV to be
determined, but it obscures details of the relative distribution and
tissue tropism of individual virus variants. Previously we devel-
oped an EGFP-encoding RG system for DWV [25] based upon the
VDD genome and designated DWVE (for convenience here
renamed to VDDE). We used VDDE to define whether the primary
infection also affects the distribution of the superinfecting virus.
Furthermore, we constructed a full length DWV type A genome,
designated DDD (Fig. S1), and similarly investigated superinfection
of DDD infected pupae. Pupae that had received an initial
injection of 102 GE of DDD, VDD, VVD or VVV were inoculated 24 h
later with 106 GE of VDDE. Live pupae were analysed by confocal
microscopy for the presence of the EGFP signal (Fig. 3). Three
regions of each pupa were visualised—the head, the developing
wing and the abdomen—as we have previously demonstrated
significant virus accumulation in these locations [25].
Injection of VDDE in the absence of a primary infection
(“Mock→VDDE” group) resulted in efficient expression of EGFP
throughout the pupa 24 h post-inoculation (Fig. 3a–c). In the case
of superinfection, the EGFP signal could be seen 24 h later only in
pupae where VVV was used as a primary infecting genotype
(Fig. 3h and i). In these pupae, the number of fluorescent foci was
lower when compared to the “Mock→ VDDE” group infected for
the same 24 h period (Fig. 3, panels a–c vs. g–i). No EGFP signal
was visible upon superinfection with VDDE after 24 h in pupae first
injected with VVD, VDD and DDD (data not shown). At 4–5 days
post-inoculation with VDDE there were also differences observed
in the levels and distribution of the reporter protein. For example,
no EGFP signal was found in the wings after primary inoculation
with VVD or DDD (Fig. 3, panels n and t vs. e and k). Visible EGFP
expression was detected in the head and abdomen in the pupae
from these injection groups after 4–5 days but the extent and
number of fluorescent foci was reduced when compared to the
“Mock→ VDDE” and “VVV→ VDDE” pupae (Fig. 3, panels m, o, s
and u vs. panels d, f, j and l). In contrast to the “Mock→VDDE” and
“VVV→ VDDE” samples, only a fraction of pupae in “VVD→ VDDE”
and “DDD→ VVDE” groups exhibited detectable EGFP signal in
each of the body sites under analysis (Table S2). Finally, pupae
initially injected with VDD did not show any detectable EGFP
signal even 6 days after superinfection with VDDE (Fig. 3p–r,
Fig. S6), suggesting again that greater sequence identity restricts
the activity of the superinfecting virus.
To confirm that the external analysis of the intact living pupae
was representative, selected samples were dissected. Tissue
samples, including parts of the digestive tract, wing rudiments,
thoracal muscle tissue, brain and cephalic glands were visualised
by confocal microscope (Fig. S6). This analysis recapitulated the
pattern of fluorescence observed by previous visualisation of
intact pupae. To complement the microscopy data, we quantified
DWV RNA in selected pupae by qPCR at 24 h and 5 days post
superinfection (Fig. S7). Analysis by qPCR revealed that a
proportion of the VDDE population has lost the non-essential
EGFP-coding sequences evidenced by the EGFP/RdRp ratio in the
“Mock→VDDE” group. This instability of EGFP-expressing viruses
has previously been reported for DWV [40] and poliovirus [41].
However, sufficient EGFP-expressing reporter viruses remained in
the population to allow their detection by microscopy and RNA
quantification 5 days post-injection. The results of qPCR have
shown that there was a good agreement between the amount of
genomic RNA and the observed level of fluorescence.
Localisation of DWV in coinfected and superinfected pupae
using two-colour microscopy
In order to visualise the distribution of infection with different
DWV variants we used EGFP- and mCherry-expressing viruses,
VDDE, VVDE, and VVVmC (with subscript E and mC indicating the
EGFP or mCherry reporter respectively, Fig. S1). For coinfection,
pupae were injected with equimolar mixtures of VVDE or VDDE
and VVVmC and analysed under the confocal microscope 1–5 days
post-inoculation. We could readily detect red and green
fluorescent signals present in the same tissues of virus-injected
pupae as previously described [25], including multiple tissues of
the digestive tract, wings and head tissues. The reporter gene
expression sites appeared as individual punctate foci of either red
or green fluorescence, with only a few displaying dual fluores-
cence for both reporters (Fig. 4a and Fig. S8). The analysis of
VDDE–infected pupae superinfected with VVVmC and visualised by
microscopy after a further 24 h revealed a similar distribution of























Fig. 2 qPCR analysis of DWV accumulation in superinfection
conditions. Honey bee pupae received a primary injection with one
DWV variant (VVV, VDD or VVD) and a secondary injection
(superinfection) with a different variant 24 h later. DWV accumula-
tion was quantified 5 (grey shading) and 7 (no shading) days after
the second injection. Primer sets specifically targeting the viral
polymerase or a structural protein encoding region of DWV type A
or type B were used to detect accumulation of each of the injected
variants. Data points represent DWV levels in individual samples
with two points of different colour corresponding to different virus
variants (red for VDD, blue for VVV, and purple for VVD respectively)
in the same pupa (or in individual pupae for VVV, VDD or VVD only
injected samples). Error bars show mean ± SD for each virus variant
in each injection group, GE—genome equivalents. ANOVA: p < 0.05
for “Mock→VDD” vs. “VVD→ VDD”, “Mock→VVD” vs. “VDD→ VVD”,
“Mock→VVD” vs. “VVV→ VVD”, “Mock→VVV” vs. “VVD→ VVV” at
7 days time point.
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Recombination between VDD and VVV DWV
The interpretation of the superinfection studies is based upon
sequence-specific quantification of particular regions of the virus
genome by qPCR. This interpretation could be confounded by
extensive levels of genetic recombination, a natural consequence of
coinfection with related viruses [42]. Genetic recombination of RNA
viruses requires that both parental genomes are present within an
individual cell [43]. Since our microscopy analysis had detected only
limited numbers of apparently dually infected foci during mixed
infections, we conducted further analysis to investigate the presence
and identity of viral recombinants, and the influence of the order of
virus acquisition on recombination, using next generation sequen-
cing. Illumina paired-reads were generated from PCR amplicons of a
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Fig. 3 EGFP signal localisation in VDDE injected honey bee pupae analysed by confocal microscopy. Combined white-field and fluorescent
images are shown for convenience of interpretation. Pupae were analysed 1 and 4–5 days after the second injection. For VVD, VDD and DDD
primary infection groups only samples incubated for 4–5 days are shown, as no EGFP was detected after 1 day. Scale bars correspond to 500 μm.
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infected with VDD and challenged with VVV, or vice versa (samples
“VVV→ VDD” and “VDD→ VVV” at 5 or 7 days after superinfection).
Recombination junctions were detected across the entirety of the
DWV genome in all samples analysed with ‘hotspots’ of recombina-
tion denoted by an increased number of aligned reads identified at
numerous points in the genome (Fig. 5b, Table S3), including some
previously reported [21]. The percentage of reads corresponding to
recombination junctions varied in individual pupae from 1–2.2% of
all mapped reads (Fig. S9). In all cases approximately equal
proportions of recombinants were detected with VVV or VDD as
the 5′-acceptor partners (terminology assumes that recombination
occurs during negative strand synthesis [42, 44]). In several instances
we detected the same recombination junction with both VVV and
VDD as the 5′-acceptor. Our analysis also revealed recombination
sites in which the 5′ was only ever derived from one variant or the
other (red and blue points in Fig. 5b, Table S3). These results
demonstrate that although superinfecting virus recombines readily
with an established variant, the recombinant population remains a
minor component of the total virus population, and is well below
the level expected to confound our analysis of competition between
extant and superinfecting viruses.
DISCUSSION
The global distribution and ubiquitous nature of DWV [14, 19],
transmitted vertically and horizontally in honey bees [15, 45, 46],
inevitably means that when vectored by Varroa it is introduced
to the host as a superinfecting virus. As such, there is the
potential for competition for cellular resources in coinfected
tissues, or the possibility of a pre-existing infection retarding or
inhibiting superinfection through molecular mechanisms includ-
ing SIE or the immune responses induced by the initial
Mock    VVV






























Fig. 4 Confocal microscopy analysis of honey bee pupae coinfected or superinfected with DWV variants encoding EGFP and mCherry. a
Coinfection: “VDDE+ VVVmC” or “VVDE+ VVVmC” panels show red (mCherry) and green (EGFP) fluorescence signals detected in the abdomen
of intact pupae (upper row) or in the dissected tissues of the digestive tract (rectum tissue shown as an example). Scale bars correspond to
500 μm. b Superinfection: upper panel—abdomen of an intact pupa initially infected with VDDE and superinfected 24 h later with VVVmC
analysed 24 h after the second injection; lower panel—abdomen of an intact pupa injected with VVVmC only and analysed 24 h post-
inoculation. Scale bars correspond to 500 μm c Magnified image of highlighted region (from a) of pupa coinfected with VDDE+ VVVmC.
Individual images for EGFP and mCherry signals, and a combined image for both fluorophores are shown. Arrows indicate individual foci of
infection exhibiting both EGFP and mCherry expression. Scale bars correspond to 100 μm.
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virus. There are at least two distinct types of DWV circulating
globally—type A and type B—with documented differences in
their distribution [8, 18, 22] and, perhaps, pathogenesis
[13, 19, 23, 25]. If the outcome of superinfection always favoured
one virus type it would influence transmission of DWV variants
potentially accounting for their geographic distribution and—if
associated with differences in virulence—the impact on the
honey bees.
SIE has been reported for DWV, with the suggestion that bees
bearing a type B virus were protected from subsequent type A
transmitted from infesting Varroa mites [10]. SIE is described for
several human, animal and plant viruses [26–35], and may operate
via a number of molecular mechanisms [26, 27, 30, 31, 47–50].
Precedents already exist in plants with milder forms of a virus
providing protection against more virulent strains [51, 52] and the
recent spread of DWV type B in the USA [8, 22] could be
interpreted as an indirect consequence of SIE, with bees
harbouring this virus less susceptible to infection by DWV type
A. However, there are other potential differences between DWV
types such as the ability of variants with type B capsid to replicate
in Varroa [25, 53], which may enhance its spread over the non-
propagative transmission reported for type A [54].
The availability of a RG system allowed us to investigate the






























































Fig. 5 Genomic recombination events observed between VVV and VDD DWV variants in a superinfected honey bee pupa. a Mapped
recombination events in a honey bee pupa initially infected with VVV and superinfected with VDD DWV. The plot shows recombination events
occurring along the full length of the DWV genome, with the VDD genome length shown on the Y-axis and VVV shown on the X-axis. Each
bubble represents a unique recombination site and bubble size is determined by the number of mapped and aligned reads for this site
obtained using ViReMa analysis. The colour of the bubble indicates the direction of recombination, with blue representing VVV as 5′-acceptor
and VDD as 3′-donor and those in red with VDD as 5′-acceptor and VVV as 3′-donor. b The most frequently observed recombination junctions
in all pupal samples analysed, shown at the recombination junction between VVV and VDD genomes. The junctions shown in black occurred
with similar frequency in both directions. Those shown in blue occurred predominantly with VVV as 5′-acceptor and VDD as 3′-donor and
those in red with VDD as 5′-acceptor and VVV as 3′-donor sequences.
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and B in individual honey bees. We found that when coinfected
DWV type A and B (VDD and VVV variants) demonstrate broadly
similar levels of replication (Fig. 1b). In contrast, in sequential
infections, either of virus-fed larvae or injected pupae, super-
infecting DWV variants showed delayed replication (Fig. 1). This
delay was dependent upon the genetic similarity of the primary
and secondary viruses and appeared transient in certain pairings.
In genetically divergent pairings (e.g. “VDD→ VVV” and “VVV→
VDD”) high levels of both viruses were reached after a prolonged
incubation period. In contrast, where the extent of genetic identity
between the primary and secondary virus was greater, the
superinfecting virus failed to ‘catch up’, even after 7 days (Fig. 2).
This was most dramatically demonstrated using two genomes that
differed by just four nucleotides (VVDS and VVDH variants), in
which case the superinfecting virus remained undetectable after
6 days incubation (Fig. S5). In addition, we found that delayed
accumulation of the genetically similar superinfecting DWV
variants is not specific to honey bee host and was also observed
in bumble bees, a species susceptible to DWV infection when
directly injected (Fig. S4) [38].
We extended our analysis in honey bee pupae using reporter
gene-expressing viruses and demonstrated that replication,
characterised by the expression of the fluorescent protein, was
inversely related to the level of genetic identity between the
primary and superinfecting viruses (Fig. 3). For example, VDDE
replicated extensively, albeit somewhat delayed when compared
with VDDE-only infected pupae, in pupae that had received VVV as
the primary virus (Fig. 3j–l), but was undetectable in pupae initially
inoculated with VDD (Fig. 3p–s). Notably, in each case where the
superinfecting virus showed reduced replication after extended
incubation, dominance in the replication showed no directionality
according to virus type and was due solely to the order of
addition. Based on this data it is likely that sequential infection
with DWV type A and B will result in both viruses replicating to
maximal levels before eclosion of either worker or drone brood
pupae (which pupate for ~12 or ~14 days respectively). It remains
to be determined whether the delay we demonstrate is sufficient
to influence the colony-level virus population, or that carried and
transmitted by Varroa.
Where cellular coinfection occurs, viruses have the opportunity
to genetically recombine. This is a widespread phenomenon in the
single-stranded positive-sense RNA viruses [55, 56] and has
previously been documented in DWV [6–9]. Our microscopy
analysis of honey bee pupae infected with two reporter-
expressing DWV variants predominantly demonstrated non-
colocalised expression of the fluorescent signal. However, small
numbers of dual-infection foci were detected, directly implying
that the opportunity for recombination exists (Fig. 4c and Fig. S8).
Using next generation sequencing we confirmed the formation of
recombinants and characterised the recombination products by
analysis of the viral RNA in pupae reciprocally superinfected with
VDD and VVV. 1–2.2% of mapped reads spanned recombination
junctions, with no evidence for any bias in their directionality
(VDD/VVV or VVV/VDD; Fig. S9). Although these junctions mapped
throughout the DWV genome, the greatest number were
concentrated in the region of the genome encoding the junction
of the structural and non-structural proteins (Fig. 5a). This
observation matches that found for other picornaviruses and
reflects the mix’n’match modular nature of the Picornavirales
genome [6, 7, 9, 18, 21]. In this, functional capsid-coding modules
can, through recombination, be juxtaposed with non-structural
coding modules from a different parental genome [57]. A small
number of recombination junctions (~350 of 35750 unique
junctions mapped) plotted as outliers from the diagonal of
genome-length recombinants. Analysis of these sequences
showed that the majority were out of frame deletions (Woodford,
unpublished), and so incapable of replicating. Our studies using
analogous approaches in other RNA viruses show that these types
of aberrant products are not unusual and reflect the random
nature of the molecular mechanism of recombination [44, 58].
The competition we demonstrate in sequential DWV infections
appears to be guided by the amount of genetic identity between
the viruses. This suggests it is most likely mediated via RNA
interference (RNAi). In arthropods antiviral RNAi response acts via
generation of short double stranded RNAs (siRNA) from virus RNA
replication intermediates through cleavage by the enzyme Dicer.
These are further used by the RNA induced silencing complex to
target the destruction of complementary sequences [59, 60].
Hence viral RNA genomes exhibiting greater identity are likely to
generate higher numbers of cross-reactive siRNAs while the
differences between these siRNA and the target virus genome
might have a significant impact [18]. Previous analysis of the RNAi
population in DWV-infected honey bees demonstrated that 75%
of DWV-specific short RNA are 21/22 mers [21]. Although DWV
type A and B exhibit ~85% genetic identity it is not contiguous
(Fig. S1), but is instead distributed in ~1350 short regions of 1–389
nucleotides. Less than 4% of these identical regions are 21
nucleotides or longer, and therefore capable of generating
perfectly complementary siRNAs. Recalculation of the identity
between genomes having excluded sequences under 21 nucleo-
tides demonstrates that there is only 34% genetic identity
between DDD and VVV (Table S4). Comparing the figures from
this analysis and the quantification of DWV accumulation in
superinfected pupae suggests a clear relationship between the
extent of the competition observed and the genetic identity of
contiguous sequences. It is already known that exogenous RNAi
can control DWV and other RNA viruses of honey bees [61–63],
and in our preliminary studies we have shown that RNAi-mediated
suppression of Dicer leads to both increased pathogenesis and
viral loads in DWV-infected bees (Fig. S10). Further research will be
required to determine the impact of RNAi in competition between
superinfecting DWV variants and its potential exploitation in
studies to develop cross-reactive vaccines against DWV [36]. These
future studies will need to take account of the disrupted
complementarity between the genomes (Table S4), the uneven
distribution of the RNAi response mapped to the genomic RNA of
the infecting virus [21], and both the variation acceptable within
the RNAi seed sequence and the RNA structure of the target.
Sequential or simultaneous infections with DWV is an inevitable
consequence of the multiple routes by which the virus can be
acquired—vertically, horizontally per os and vectored by Varroa.
Our studies demonstrate that it is the order of acquisition, not the
specific type of DWV, that determines the outcome of sequential
or superinfection. The role of genetic identity in competition
between DWV variants at an individual and landscape scale is
likely to be a fruitful area of research, and may allow the future
development of rationally designed vaccines against DWV that
exploit the conserved RNAi response of the infected host.
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